{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:26:43Z","timestamp":1790033203192,"version":"4.0.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Stroke survivors are at significantly increased risk of cognitive impairment, which affects patients\u2019 independence of activities of daily living (ADLs), social engagement, and neurological function deficit. Many studies have been done to evaluate the efficacy and safety of post-stroke cognitive impairment (PSCI) treatment, and due to the largely inconsistent clinical data, there is a need to summarize and analyze the published clinical research data in this area.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> An umbrella review was performed to evaluate the efficacy and safety of PSCI therapies.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Three independent authors searched for meta-analyses and systematic reviews on PubMed, the Cochrane Library, and the Web of Science to address this issue. We examined ADL and Barthel index (BI), Montreal Cognitive Assessment (MoCA), neurological function deficit as efficacy endpoints, and the incidence of adverse events as safety profiles.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In all, 312 studies from 19 eligible publications were included in the umbrella review. The results showed that angiotensin-converting enzyme inhibitors (ACEI) and N-methyl-D-aspartate (NMDA) antagonists, cell therapies, acupuncture, and EGB76 can improve the MoCA and ADL, and the adverse effects were mild for the treatment of PSCI. Moreover, Vinpocetine, Oxiracetam, Citicoline, thrombolytic therapy, Actovegin, DL-3-n-Butylphthalide, and Nimodipine showed adverse events or low article quality in patients with PSCI. However, the research evidence is not exact and further research is needed.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our study demonstrated that ACEI inhibitors (Donepezil) and NMDA antagonists (Memantine), EGB761, and acupuncture are the ADL and BI, MoCA, and neurological function deficit medication\/therapy, respectively, for patients with PSCI.<\/jats:p><jats:p><jats:bold>Clinical Trial Registration:<\/jats:bold><jats:ext-link>https:\/\/inplasy.com\/inplasy-2022-11-0139\/<\/jats:ext-link>; Identifier: INPLASY2022110139.<\/jats:p>","DOI":"10.3389\/fphar.2023.1207075","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:47:00Z","timestamp":1692874020000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["The efficacy and safety of post-stroke cognitive impairment therapies: an umbrella review"],"prefix":"10.3389","volume":"14","author":[{"given":"Yongbiao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000346602","article-title":"Long-term treatment with citicoline may improve poststroke vascular cognitive impairment","volume":"35","author":"Alvarez-Sabin","year":"2013","journal-title":"Cerebrovasc. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"CD003120","DOI":"10.1002\/14651858.CD003120.pub2","article-title":"Ginkgo biloba for cognitive impairment and dementia","volume":"1","author":"Birks","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/acupmed-2013-010363","article-title":"Acupuncture for vascular mild cognitive impairment: a systematic review of randomised controlled trials","volume":"31","author":"Cao","year":"2013","journal-title":"Acupunct. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.pharep.2019.01.012","article-title":"Chronic cerebral hypoperfusion-induced memory impairment and hippocampal long-term potentiation deficits are improved by cholinergic stimulation in rats","volume":"71","author":"Damodaran","year":"2019","journal-title":"Pharmacol. Rep. Jun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jrsm.1532","article-title":"The application of AMSTAR2 in 32 overviews of systematic reviews of interventions for mental and behavioural disorders: a cross-sectional study","volume":"13","author":"De Santis","year":"2022","journal-title":"Res. Synth. Methods"},{"key":"B6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3143\/geriatrics.44.448","article-title":"The benefit of angiotensin converting enzyme inhibitor for geriatric syndrome in the elderly]","volume":"44","author":"Ebihara","year":"2007","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"B7","doi-asserted-by":"publisher","first-page":"810297","DOI":"10.3389\/fphar.2021.810297","article-title":"Efficacy and safety of DL-3-n-butylphthalide in the treatment of poststroke cognitive impairment: a systematic review and meta-analysis","volume":"12","author":"Fan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11920-020-01147-2","article-title":"Considerations and current trends in the management of the geriatric patient on a consultation-liaison service","volume":"22","author":"Glass","year":"2020","journal-title":"Curr. Psychiatry Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.19540\/j.cnki.cjcmm.20190902.502","article-title":"Systematic review and Meta-analysis of efficacy and safety of Compound Congrong Yizhi Capsules on vascular cognitive impairment]","volume":"45","author":"Gou","year":"2020","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/STROKEAHA.116.014321","article-title":"ARTEMIDA trial (A randomized trial of efficacy, 12 Months international double-blind Actovegin): a randomized controlled trial to assess the efficacy of Actovegin in poststroke cognitive impairment","volume":"48","author":"Guekht","year":"2017","journal-title":"Stroke"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-2238.2015.07.012","article-title":"Analysis on clinical efficacy and safety of oxiracetam for the treatment of cognitive dysfunction after stroke LE","volume":"50","author":"Huahui","year":"2015","journal-title":"Jiangxi Medical Journal"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15333175211016185","DOI":"10.1177\/15333175211016185","article-title":"The role of cilostazol and inflammation in cognitive impairment after ischemic stroke","volume":"36","author":"Huang","year":"2021","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"B30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.4103\/1673-5374.249228","article-title":"Comparative efficacy and safety of cognitive enhancers for treating vascular cognitive impairment: systematic review and Bayesian network meta-analysis","volume":"14","author":"Jin","year":"2019","journal-title":"Neural Regen Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"CD011971","DOI":"10.1002\/14651858.CD011971.pub2","article-title":"Antihypertensive withdrawal for the prevention of cognitive decline","volume":"11","author":"Jongstra","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.2174\/1570161117666190618164443","article-title":"Herbal medicine for vascular dementia: an overview of systematic reviews","volume":"18","author":"Kim","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00415-019-09630-4","article-title":"Post-stroke cognitive impairment as an independent predictor of ischemic stroke recurrence: PICASSO sub-study","volume":"267","author":"Kwon","year":"2020","journal-title":"J Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1089\/neu.2017.5561","article-title":"Enhancement of brain d-serine mediates recovery of cognitive function after traumatic brain injury","volume":"35","author":"Liraz-Zaltsman","year":"2018","journal-title":"J. Neurotrauma"},{"key":"B15","doi-asserted-by":"publisher","first-page":"CD000147","DOI":"10.1002\/14651858.CD000147","article-title":"Nimodipine for primary degenerative, mixed and vascular dementia","volume":"3","author":"Lopez-Arrieta","year":"2002","journal-title":"Cochrane Database Syst. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2165\/11319230-000000000-00000","article-title":"Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders","volume":"70","author":"Malykh","year":"2010","journal-title":"Drugs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","article-title":"Post-stroke dementia - a comprehensive review","volume":"15","author":"Mijajlovic","year":"2017","journal-title":"BMC Med."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1674-4055.2016.11.06","article-title":"The effect of salvianolate on motor and cognitive function of patients with acute cerebral infarction: a systematic review","volume":"8","author":"Ming","year":"2016","journal-title":"Chin. J. Evid. Based Cardiovasc. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e12374","DOI":"10.1097\/MD.0000000000012374","article-title":"Salvianolate injection in the treatment of acute cerebral infarction: a systematic review and a meta-analysis","volume":"97","author":"NanZhu","year":"2018","journal-title":"Med. Baltim."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1212\/WNL.0000000000012781","article-title":"Global epidemiology of stroke and access to acute ischemic stroke interventions","volume":"97","author":"Saini","year":"2021","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2174\/1567205019666220120112301","article-title":"Comparative efficacy and acceptability of cholinesterase inhibitors and memantine based on dosage in patients with vascular cognitive impairment: a network meta-analysis","volume":"19","author":"Shi","year":"2022","journal-title":"Curr. Alzheimer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"CD003119","DOI":"10.1002\/14651858.CD003119","article-title":"Vinpocetine for cognitive impairment and dementia","volume":"1","author":"Szatmari","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3233\/JAD-140837","article-title":"Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis","volume":"43","author":"Tan","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neulet.2015.11.014","article-title":"Chronic exposure to aluminum and risk of alzheimer's disease: a meta-analysis","volume":"610","author":"Wang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.13422\/j.cnki.syfjx.20201151","article-title":"Systematic evaluation of clinical efficacy and safety of traditional Chinese medicine for post stroke cognitive impairment","volume":"26","author":"Wei","year":"2016","journal-title":"Chinese Journal of Experimental Traditional Medical Formulae"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.19540\/j.cnki.cjcmm.20200309.501","article-title":"Systematic evaluation and Meta-analysis of efficacy and safety of Tianzhi Granules in treatment of vascular cognitive impairment]","volume":"45","author":"Wen-Yue","year":"2020","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/NDT.S350266","article-title":"Long-term functionality prediction for first time ischemic middle cerebral artery stroke patients receiving conventional medical treatment","volume":"18","author":"Yang","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1166\/jnn.2020.18863","article-title":"A meta-analysis of Au\/polypropionic acid Nanoparticles loaded with Olacetam for the treatment of vascular cognitive impairment","volume":"20","author":"Yi","year":"2020","journal-title":"J. Nanosci. Nanotechnol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fnagi.2019.00086","article-title":"Meta-analysis on the efficacy and safety of hyperbaric oxygen as adjunctive therapy for vascular dementia","volume":"11","author":"You","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuroscience.2014.01.012","article-title":"Modulating autophagy affects neuroamyloidogenesis in an in vitro ischemic stroke model","volume":"263","author":"Zhang","year":"2014","journal-title":"Neuroscience"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1207075\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:47:09Z","timestamp":1692874029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1207075\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":34,"alternative-id":["10.3389\/fphar.2023.1207075"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1207075","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"article-number":"1207075"}}